Literature DB >> 20044602

Retinoid-induced histone deacetylation inhibits telomerase activity in estrogen receptor-negative breast cancer cells.

Sharla M O Phipps1, William K Love, Teresa White, Lucy G Andrews, Trygve O Tollefsbol.   

Abstract

BACKGROUND: Multiple mechanisms regulate cancer-associated telomerase activity at the level of human telomerase reverse transcriptase (hTERT) transcription which may serve as novel targets for anticancer approaches.
MATERIALS AND METHODS: The effects of prolonged all-trans retinoic acid (ATRA) exposure on hTERT regulation in estrogen receptor-negative SK-BR-3 breast cancer cells were examined.
RESULTS: ATRA had a profound effect on the morphology and proliferation rate of the SK-BR-3 cells. ATRA also hindered the ability of these cancer cells to grow independently, rendering them more like normal somatic cells. The effect of ATRA on the decrease of telomerase activity was found to be associated with a rapid decrease in histone H3-lysine 9 acetylation (H3-K9-Ac) of the hTERT promoter. Extended-exposure to ATRA in these cells also caused the initiation of a putative compensatory mechanism, counteracting the induced surge in apoptosis.
CONCLUSION: A rapid decrease of H3-K9 acetylation at the hTERT promoter could be an important mechanism by which ATRA shuts down telomerase activity and mediates its antitumor effects in estrogen receptor-negative breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20044602      PMCID: PMC2888005     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  14 in total

Review 1.  Translating the histone code.

Authors:  T Jenuwein; C D Allis
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

2.  Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.

Authors:  P Fitzgerald; M Teng; R A Chandraratna; R A Heyman; E A Allegretto
Journal:  Cancer Res       Date:  1997-07-01       Impact factor: 12.701

3.  The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells.

Authors:  Nathan J Hansen; Rebecca C Wylie; Sharla M O Phipps; William K Love; Lucy G Andrews; Trygve O Tollefsbol
Journal:  Int J Oncol       Date:  2007-03       Impact factor: 5.650

4.  hTERT is expressed in cancer cell lines despite promoter DNA methylation by preservation of unmethylated DNA and active chromatin around the transcription start site.

Authors:  Rebekah L Zinn; Kevin Pruitt; Sayaka Eguchi; Stephen B Baylin; James G Herman
Journal:  Cancer Res       Date:  2007-01-01       Impact factor: 12.701

5.  Activation of retinoic acid receptor alpha is sufficient for full induction of retinoid responses in SK-BR-3 and T47D human breast cancer cells.

Authors:  S M Schneider; M Offterdinger; H Huber; T W Grunt
Journal:  Cancer Res       Date:  2000-10-01       Impact factor: 12.701

6.  Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity.

Authors:  Isabelle Guilleret; Pu Yan; Fabienne Grange; Richard Braunschweig; Fred T Bosman; Jean Benhattar
Journal:  Int J Cancer       Date:  2002-10-01       Impact factor: 7.396

7.  Epigenetic regulation of telomerase in retinoid-induced differentiation of human leukemia cells.

Authors:  William K Love; Joel B Berletch; Lucy G Andrews; Trygve O Tollefsbol
Journal:  Int J Oncol       Date:  2008-03       Impact factor: 5.650

8.  Retinoic acid induced death of ovarian carcinoma cells correlates with c-myc stimulation.

Authors:  G Krupitza; W Hulla; H Harant; E Dittrich; E Kallay; H Huber; T Grunt; C Dittrich
Journal:  Int J Cancer       Date:  1995-05-29       Impact factor: 7.396

9.  Retinoic acid resistance of estradiol-independent breast cancer cells coincides with diminished retinoic acid receptor function.

Authors:  B van der Burg; B M van der Leede; L Kwakkenbos-Isbrücker; S Salverda; S W de Laat; P T van der Saag
Journal:  Mol Cell Endocrinol       Date:  1993-02       Impact factor: 4.102

10.  Dual role of DNA methylation inside and outside of CTCF-binding regions in the transcriptional regulation of the telomerase hTERT gene.

Authors:  S Renaud; D Loukinov; Z Abdullaev; I Guilleret; F T Bosman; V Lobanenkov; J Benhattar
Journal:  Nucleic Acids Res       Date:  2007-01-31       Impact factor: 16.971

View more
  6 in total

1.  Autophagy inhibition synergistically enhances anticancer efficacy of RAMBA, VN/12-1 in SKBR-3 cells, and tumor xenografts.

Authors:  Abhijit M Godbole; Puranik Purushottamachar; Marlena S Martin; Constantine Daskalakis; Vincent C O Njar
Journal:  Mol Cancer Ther       Date:  2012-02-14       Impact factor: 6.261

2.  Retinoic acid and cAMP inhibit rat hepatocellular carcinoma cell proliferation and enhance cell differentiation.

Authors:  M Ionta; M C Rosa; R B Almeida; V M Freitas; P Rezende-Teixeira; G M Machado-Santelli
Journal:  Braz J Med Biol Res       Date:  2012-05-24       Impact factor: 2.590

3.  Retinoic acid and cancer treatment.

Authors:  Mei-Chih Chen; Shih-Lan Hsu; Ho Lin; Tsung-Ying Yang
Journal:  Biomedicine (Taipei)       Date:  2014-11-28

Review 4.  Telomerase Regulation from Beginning to the End.

Authors:  Deanna Elise MacNeil; Hélène Jeanne Bensoussan; Chantal Autexier
Journal:  Genes (Basel)       Date:  2016-09-14       Impact factor: 4.096

Review 5.  Telomerase as a useful target in cancer fighting-the breast cancer case.

Authors:  Hanna Holysz; Natalia Lipinska; Anna Paszel-Jaworska; Blazej Rubis
Journal:  Tumour Biol       Date:  2013-04-05

Review 6.  Retinoic Acids in the Treatment of Most Lethal Solid Cancers.

Authors:  Lara Costantini; Romina Molinari; Barbara Farinon; Nicolò Merendino
Journal:  J Clin Med       Date:  2020-01-28       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.